Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome
Nutrition in Clinical Practice · 2025
DOI: 10.1002/ncp.11307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrition in Clinical Practice, 2025. Verfasst von Zoe N Memel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Dietary Supplements, Life Style, Diet. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 112 Literaturangaben.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is the most common gastrointestinal (GI) disorder of the gut‐brain interaction and causes significant GI distress. The etiology of IBS is multifactorial, with food intolerances being a frequent contributing factor to IBS symptoms. Diet and lifestyle interventions are key components in comprehensive IBS care. In this review, we examine the current evidence‐based dietary approaches for treating IBS. The low‐FODMAP diet has the most robust data for improving overall symptom burden. In conjunction with guidance from a registered dietitian, certain patients may benefit from targeted dietary elimination of specific carbohydrates such as lactose or fructose or gluten. Among the nutraceuticals used to treat IBS, peppermint oil has sufficient evidence and appropriate safety data to recommend adjunctive use to reduce IBS symptoms. Although prebiotic and probiotic food sources may be beneficial to the microbiome, there is not enough evidence to support the routine use of prebiotic or probiotic supplements. Given the complexity of IBS, a holistic approach in which clinicians address a patients' diet, culture, sleep hygiene, exercise habits, and mental health may improve patients' overall quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, University of California, San Francisco, California, USA.
- Colitis and Crohn's Disease Center, University of California, San Francisco, California, USA.
ORCID-Profile: Neha D Shah, Kendall R Beck
Zitieren
APA
Memel, Z. N., Shah, N. D., & Beck, K. R. (2025). Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome. Nutrition in Clinical Practice. https://doi.org/10.1002/ncp.11307
Vancouver
Memel ZN, Shah ND, Beck KR. Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome. Nutrition in Clinical Practice. 2025. doi:10.1002/ncp.11307
BibTeX
@article{Memel2025,
author = {Memel, Zoe N and Shah, Neha D and Beck, Kendall R},
title = {Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome},
journal = {Nutrition in Clinical Practice},
year = {2025},
doi = {10.1002/ncp.11307}
}
EUVIMED